Generic Name:
abiraterone acetate and prednisone/dexamethasone with docetaxel
Project Status:
Received
Therapeutic Area:
Metastatic castration sensitive prostate cancer (mCSPC).
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
PC0298-000
Call for patient/clinician input closed:
Tumour Type:
Genitourinary
Details
Submission Type:
Non-sponsored Submission
Indications:
For the treatment of metastatic castration sensitive prostate cancer in combination with androgen deprivation therapy.